{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:19Z","timestamp":1761863059057},"reference-count":41,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1253\/circj.cj-11-0586","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T05:20:44Z","timestamp":1319001644000},"page":"2798-2804","source":"Crossref","is-referenced-by-count":10,"title":["Drug-Eluting vs. Bare-Metal Stents for Treatment of Acute Myocardial Infarction With Renal Insufficiency"],"prefix":"10.1253","volume":"75","author":[{"given":"Eun Hui","family":"Bae","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yup","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Korea University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hwan","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Heon","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hoon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Seok","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Seong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Kwon","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"},{"name":"Cardiovascular Research Institute of Chonnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Wan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Korea Acute Myocardial Infarction Registry investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System, USRDS 1998 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1998. Available at:http:\/\/www.usrds.org\/adr_1998.htm (accessed September 12, 2003)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cardarelli F, Bellasi A, Veledar E, Vaccarino V, Raggi P. Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: A single tertiary center experience. Am Heart J 2008; 155: 1027-1032.","DOI":"10.1016\/j.ahj.2008.01.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in collaboration with the National Kidney Foundation. Circulation 2006; 114: 1083-1087.","DOI":"10.1161\/CIRCULATIONAHA.106.177321"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Oda E. Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients. Circ J 2010; 74: 1121-1126.","DOI":"10.1253\/circj.CJ-10-0377"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.","DOI":"10.1056\/NEJMoa041365"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92: 509-514.","DOI":"10.1016\/S0002-9149(03)00716-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Goto K, Shiode N, Shirota K, Fukuda Y, Kitamura F, Tominaga K, et al. Impact of impaired renal function and diabetes on long-term prognosis in patients undergoing primary angioplasty for acute coronary syndrome. Intern Med 2008; 47: 907-913.","DOI":"10.2169\/internalmedicine.47.0932"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol 2009; 133: 213-222.","DOI":"10.1016\/j.ijcard.2007.12.040"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. James SK, Stenestrand U, Lindb&auml;ck J, Carlsson J, Scherst&eacute;n F, Nilsson T, et al; SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009; 360: 1933-1945.","DOI":"10.1056\/NEJMoa0809902"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jeong YH, Hong MK, Lee CW, Carlsson J, Scherst&eacute;n F, Nilsson T, et al. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 2008; 125: 36-40.","DOI":"10.1016\/j.ijcard.2007.02.026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson BH, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial. Am Heart J 2005; 150: 1163-1170.","DOI":"10.1016\/j.ahj.2005.01.032"},{"key":"12","unstructured":"12. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006; 18: 405-408."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fukuta H, Ohte N, Mukai S, Asada K, Wakami K, Goto T, et al. Relationship between renal function, aortic stiffness and left ventricular function in patients with coronary artery disease. Circ J 2009; 73: 1740-1745.","DOI":"10.1253\/circj.CJ-09-0185"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974-980.","DOI":"10.1161\/01.CIR.0000027560.41358.B3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Le Feuvre C. Angioplasty and stenting in patients with renal disease. Heart 2000; 83: 7-8.","DOI":"10.1136\/heart.83.1.7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457.","DOI":"10.1016\/j.jacc.2004.11.067"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. van Domburg RT, Hoeks SE, Welten GM, Chonchol M, Elhendy A, Poldermans D. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 2008; 19: 158-163.","DOI":"10.1681\/ASN.2006101112"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92: 509-514.","DOI":"10.1016\/S0002-9149(03)00716-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003; 14: 2373-2380.","DOI":"10.1097\/01.ASN.0000083900.92829.F5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109: 2290-2295.","DOI":"10.1161\/01.CIR.0000126826.58526.14"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sadeghi HM, Stone GW, Grines CL Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769-2775.","DOI":"10.1161\/01.CIR.0000103623.63687.21"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: A report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv 2009; 2: 37-45.","DOI":"10.1016\/j.jcin.2008.06.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119.","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.","DOI":"10.1056\/NEJMoa032441"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kuchulakanti PK, Torguson R, Chu WW, Canos Da, Rha SW, Clavijo L, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006; 97: 792-797.","DOI":"10.1016\/j.amjcard.2005.10.018"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, et al. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2009; 2: 309-316.","DOI":"10.1161\/CIRCINTERVENTIONS.108.828954"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, et al<i>.<\/i> Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J 2009; 158: 92-98.","DOI":"10.1016\/j.ahj.2009.04.013"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sasao H, Hotta D, Maeda T, Saito N, Takagi S, Shimamoto K, et al. Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis. Int Heart J 2007; 48: 689-700.","DOI":"10.1536\/ihj.48.689"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.","DOI":"10.1253\/circj.72.56"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-1529.","DOI":"10.1253\/circj.71.1525"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gawaz MP, Dobos G, Spath M, Schollmeyer P, GUrland HJ, Mujais SK, et al. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 1994; 5: 36-46.","DOI":"10.1681\/ASN.V5136"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Mezzano D, Tagle R, Panes O, Perez M, Downey P, Munoz B, et al. Hemostatic disorder of uremia: The platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 1996; 76: 312-321.","DOI":"10.1055\/s-0038-1650576"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, et al. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J 2008; 155: 687-693.","DOI":"10.1016\/j.ahj.2007.10.046"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006; 19: 317-322.","DOI":"10.1111\/j.1525-139X.2006.00179.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Best PJ, Berger PB, Davis BR, Grines CL, Sadeghi HM, Williams BA, et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial. J Am Coll Cardiol 2004; 44: 1786-1791.","DOI":"10.1016\/j.jacc.2004.07.052"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, Lv AK, et al. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention. Int J Cardiol 2009; 136: 72-79.","DOI":"10.1016\/j.ijcard.2008.04.028"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong AT, Saia F, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005; 95: 167-172.","DOI":"10.1016\/j.amjcard.2004.08.089"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402.","DOI":"10.1056\/NEJMoa071076"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Qasim A, Cosgrave J, Latib A, Ko DT, Austin PC, He Y, et al. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 2007; 100: 1619-1624.","DOI":"10.1016\/j.amjcard.2007.07.013"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 2007; 154: 688-693.","DOI":"10.1016\/j.ahj.2007.06.005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: A multicenter registry. Circulation 2007; 116: 158-162.","DOI":"10.1161\/CIRCULATIONAHA.107.692178"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/12\/75_CJ-11-0586\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T20:23:26Z","timestamp":1639254206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/12\/75_CJ-11-0586\/_article"}},"subtitle":["\u2013 Results From Korea Acute Myocardial Infarction Registry \u2013"],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-11-0586","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}